-+ 0.00%
-+ 0.00%
-+ 0.00%

VENTYX BIOSCIENCES INC - VTX3232 PHASE 2 TRIAL IN OBESITY AND CARDIOMETABOLIC RISK FACTORS RESULTS EXPECTED H2 2025

Reuters·06/17/2025 11:00:00

Please log in to view news